Antonella Sesta1, Maria Francesca Cassarino1, Mariarosa Terreni2, Alberto G Ambrogio1, Laura Libera1, Donatella Bardelli1, Giovanni Lasio3, Marco Losa4, Francesca Pecori Giraldi5,6. 1. Istituto Auxologico Italiano IRCCS, Neuroendocrinology Research Laboratory, Cusano Milanino, Milan, Italy. 2. Department of Pathology, Ospedale San Raffaele, Milan, Italy. 3. Department of Neurosurgery, Humanitas Clinical and Research Center, Rozzano, Italy. 4. Department of Neurosurgery, Ospedale San Raffaele, Milan, Italy. 5. Istituto Auxologico Italiano IRCCS, Neuroendocrinology Research Laboratory, Cusano Milanino, Milan, Italy, francesca.pecorigiraldi@unimi.it. 6. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy, francesca.pecorigiraldi@unimi.it.
Abstract
BACKGROUND: Somatic mutations in the ubiquitin-specific protease 8 (USP8) gene have recently been shown to occur in ACTH-secreting pituitary adenomas, thus calling attention to the ubiquitin system in corticotrope adenomas. OBJECTIVES: Assess the consequences of USP8 mutations and establish the role of ubiquitin on ACTH turnover in human ACTH-secreting pituitary adenomas. METHODS: USP8 mutation status was established in 126 ACTH-secreting adenomas. Differences in ACTH secretion and POMC expression from adenoma primary cultures and in microarray gene expression profiles from archival specimens were sought according to USP8 sequence. Ubiquitin/ACTH coimmunoprecipitation and incubation with MG132, a proteasome inhibitor, were performed in order to establish whether ubiquitin plays a role in POMC/ACTH degradation in corticotrope adenomas. RESULTS: USP8 mutations were identified in 29 adenomas (23%). Adenomas presenting USP8 mutations secreted greater amounts of ACTH and expressed POMC at higher levels compared to USP wild-type specimens. USP8 mutant adenomas were also more sensitive to modulation by CRH and dexamethasone in vitro. At microarray analysis, genes associated with endosomal protein degradation and membrane components were downregulated in USP8 mutant adenomas as were AVPR1B, IL11RA, and PITX2. Inhibition of the ubiquitin-proteasome pathway increased ACTH secretion and POMC itself proved a target of ubiquitylation, independently of USP8 sequence status. CONCLUSIONS: Our study has shown that USP8 mutant ACTH-secreting adenomas present a more "typical" corticotrope phenotype and reduced expression of several genes associated with protein degradation. Further, ubiquitylation is directly involved in intracellular ACTH turnover, suggesting that the ubiquitin-proteasome system may represent a target for treatment of human ACTH-secreting adenomas.
BACKGROUND: Somatic mutations in the ubiquitin-specific protease 8 (USP8) gene have recently been shown to occur in ACTH-secreting pituitary adenomas, thus calling attention to the ubiquitin system in corticotrope adenomas. OBJECTIVES: Assess the consequences of USP8 mutations and establish the role of ubiquitin on ACTH turnover in humanACTH-secreting pituitary adenomas. METHODS:USP8 mutation status was established in 126 ACTH-secreting adenomas. Differences in ACTH secretion and POMC expression from adenoma primary cultures and in microarray gene expression profiles from archival specimens were sought according to USP8 sequence. Ubiquitin/ACTH coimmunoprecipitation and incubation with MG132, a proteasome inhibitor, were performed in order to establish whether ubiquitin plays a role in POMC/ACTH degradation in corticotrope adenomas. RESULTS:USP8 mutations were identified in 29 adenomas (23%). Adenomas presenting USP8 mutations secreted greater amounts of ACTH and expressed POMC at higher levels compared to USP wild-type specimens. USP8 mutant adenomas were also more sensitive to modulation by CRH and dexamethasone in vitro. At microarray analysis, genes associated with endosomal protein degradation and membrane components were downregulated in USP8 mutant adenomas as were AVPR1B, IL11RA, and PITX2. Inhibition of the ubiquitin-proteasome pathway increased ACTH secretion and POMC itself proved a target of ubiquitylation, independently of USP8 sequence status. CONCLUSIONS: Our study has shown that USP8 mutant ACTH-secreting adenomas present a more "typical" corticotrope phenotype and reduced expression of several genes associated with protein degradation. Further, ubiquitylation is directly involved in intracellular ACTH turnover, suggesting that the ubiquitin-proteasome system may represent a target for treatment of humanACTH-secreting adenomas.
Authors: Martin Reincke; Silviu Sbiera; Akira Hayakawa; Marily Theodoropoulou; Andrea Osswald; Felix Beuschlein; Thomas Meitinger; Emi Mizuno-Yamasaki; Kohei Kawaguchi; Yasushi Saeki; Keiji Tanaka; Thomas Wieland; Elisabeth Graf; Wolfgang Saeger; Cristina L Ronchi; Bruno Allolio; Michael Buchfelder; Tim M Strom; Martin Fassnacht; Masayuki Komada Journal: Nat Genet Date: 2014-12-08 Impact factor: 38.330
Authors: V Pulkkinen; S Ezer; L Sundman; J Hagström; S Remes; C Söderhäll; D Greco; G Dario; C Haglund; J Kere; J Arola Journal: Virchows Arch Date: 2014-06-12 Impact factor: 4.064
Authors: Pietro Locantore; Rosa Maria Paragliola; Gianluca Cera; Roberto Novizio; Ettore Maggio; Vittoria Ramunno; Andrea Corsello; Salvatore Maria Corsello Journal: Int J Mol Sci Date: 2022-06-19 Impact factor: 6.208
Authors: Mateusz Bujko; Paulina Kober; Joanna Boresowicz; Natalia Rusetska; Natalia Zeber-Lubecka; Agnieszka Paziewska; Monika Pekul; Grzegorz Zielinski; Andrzej Styk; Jacek Kunicki; Jerzy Ostrowski; Janusz A Siedlecki; Maria Maksymowicz Journal: J Clin Med Date: 2021-01-20 Impact factor: 4.241
Authors: Luis Gustavo Perez-Rivas; Julia Simon; Adriana Albani; Sicheng Tang; Sigrun Roeber; Guillaume Assié; Timo Deutschbein; Martin Fassnacht; Monica R Gadelha; Ad R Hermus; Günter K Stalla; Maria A Tichomirowa; Roman Rotermund; Jörg Flitsch; Michael Buchfelder; Isabella Nasi-Kordhishti; Jürgen Honegger; Jun Thorsteinsdottir; Wolfgang Saeger; Jochen Herms; Martin Reincke; Marily Theodoropoulou Journal: Acta Neuropathol Commun Date: 2022-09-19 Impact factor: 7.578